27
KIT
incorporates smart alarms and remote monitoring
technology. And because it uses radio frequency
technology rather than chemicals to measure blood
glucose levels, it should have a longer shelf life. The folk
at GlucoRx believes the BioXensor could also prevent the
onset of Type 2 diabetes or aid in its remission, if used at
an early stage of diagnosis.
According to Chris Chapman, GlucoRx's chief
operating officer, "GlucoRx BioXensor is accurate with
a proven MARD* of 10.4%. Owing to its multi-sensor
approach, it capturing blood glucose as well as the
wearer's respiration rate, heart rate, body temperature,
activity levels, sleep and even early fall detection."
If you are asking how soon, following a series of
successful trials at Swansea University with Professor
Stephen Luzio, the team is set to conduct a further pivotal
clinical study shortly on its smaller and improved fourthgeneration
device before submitting for CE certification.
*MARD (mean absolute relative difference), the lower the
MARD, the greater the accuracy of the device. Dexcom's
G6 has a MARD of 9% and the Libre 2 is 9.3%.
www.glucorx.co.uk
Right test?
Taiwan-based medical equipment manufacturer Bionime
is currently developing its 'Rightest' CGM system. It
provides glucose level measurements at five-minute
intervals continuously for 14 days and also promises to do
away with the need for finger-pricking. The device is also
due to be capable of delivering hypo or hyper alerts.
Users place the sensor on their arm (or abdomen
for children) themselves and connect the rechargeable
transmitter. This communicates with a receiver or
smartphone, as well as Bionime's DMS cloud. Rightest is
currently at the pivotal trial stage to evaluate it for safety
and effectiveness, but the trial is not yet complete. So it
looks like early days on this one.
www.bionime.com
Dedicated NHS Diabetes Advice helpline
0345 123 2399